Found 105 matching trials
Effects of Marijuana on Symptoms of OCD PHASE1 The purpose of this pilot research study is to test whether certain compone...
Show More Location
New York State Psychiatric Institute
Learn More & Join Trial
RePOSA-Revealing the Efficacy of IHL-42X Use in Patients With OSA PHASE2 The goal of this randomised, double-blind phase II/III clinical trial is to...
Show More Location
Exalt Clinical Research
Learn More & Join Trial
Cannabinoids, Neural Synchrony, and Information Processing EARLY_PHASE1 The study examines the effects of delta-9-tetrahydrocannabinol (Δ9-THC), th...
Show More Location
VA Connecticut Healthcare System
Learn More & Join Trial
Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy PHASE3 Over the last years a rising medical need for treatment of chronic pain was...
Show More Location
Klinikum Rechts der Isar (Zentrum für Interdisziplinäre Schmerztherapie)
Learn More & Join Trial
NanaBis™ an Oro-buccal Administered delta9-Tetrahydrocannabinol (d9-THC) & Cannabidiol (CBD) Medicine for the Management of Bone Pain From Metastatic Cancers PHASE3 This is a multi-centre, long term, double blind, clinical protocol for Nana...
Show More Location
Multiple Locations
Learn More & Join Trial
Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Sub-Study I PHASE1 The overarching goal of this study is to characterize the effects of ethano...
Show More Status
Active Not Recruiting
Location
Biological Studies Unit, VA Connecticut Healthcare System
Learn More & Join Trial
Behavioral Pharmacology of THC and D-limonene PHASE1 This study will evaluate the pharmacokinetics and pharmacodynamics of vapor...
Show More Location
Johns Hopkins Behavioral Pharmacology Research Unit
Learn More & Join Trial
Cannabinoid Interactions With Central and Peripheral Pain Mechanisms in Osteoarthritis of the Knee PHASE2 This clinical trial is being done to better understand how daily treatment ...
Show More Location
University of Michigan
Learn More & Join Trial
Delta-THC in Behavioral Disturbances in Dementia PHASE2 Dementia is a common chronic condition, with predicted increasing prevalenc...
Show More Location
Radboud university medical center
Learn More & Join Trial
Cannabidiol in Patients With COVID-19 and Cardiovascular Disease or Risk Factors PHASE2 Non-critical patients, hospitalized within the previous 24 hours who tested...
Show More Location
Valleywise Health Medical Center
Learn More & Join Trial